MABPHARM-B 02181·

Gross margin --------------------79.76%--72.50%7.25%86.32%13.82%84.96%1.36%88.79%3.83% Net margin -----994.29%---622.47%371.82%---------352.00%---377.01%25.02%-240.19%136.82%-49.55%190.65%8.84%58.39% ROE -----31.12%---50.04%18.92%---------48.46%---52.58%4.12%-102.10%49.52%-143.87%41.77%36.32%180.19% ROA ---------------------32.42%---22.98%9.44%-20.23%2.75%-12.59%7.64%4.95%17.54% Revenue growth --------401.44%---------------32.53%--55.87%88.41%196.27%140.39%150.20%46.06% Attributable profit growth ---------302.02%--------------27.74%--0.69%27.04%38.89%38.19%144.65%105.77% Debt-to-assets --------------------33.11%--56.30%23.20%80.19%23.89%91.25%11.06%86.36%4.89% Current ratio ----2.19--1.670.52--------1.05--1.070.011.080.011.170.090.810.36 Operating cash flow / net profit ----1.37--0.410.95--------0.68--0.270.41-0.270.540.030.311.411.38 Operating cash flow / revenue -----1357.27%---257.18%1100.10%---------240.67%---101.73%138.94%65.85%167.58%-1.59%67.43%12.50%14.09%

Gross margin 87.99%--90.86%2.87% Net margin 1.06%--7.88%6.82% Revenue growth ----45.14%-- Attributable profit growth ----982.13%-- Debt-to-assets ----83.41%-- Current ratio ----0.84-- Operating cash flow / net profit 14.72--2.0612.66 Operating cash flow / revenue 15.56%--16.26%0.69%

Revenue ----4.80M--24.06M401.44%--------82.88M--55.92M32.53%87.16M55.87%258.23M196.27%646.10M150.20% Other income and gains --------------------14.82M--27.30M84.25%3.57M86.92%7.99M123.71%9.24M15.67% Cost of sales ----307.00K--12.51M3973.94%---------------------------- Gross profit --------------------66.11M--40.54M38.67%75.24M85.58%219.39M191.60%573.65M161.47% Selling and distribution expenses --------------------9.42M--28.21M199.41%48.92M73.41%151.57M209.79%400.82M164.45% Administrative expenses ----24.90M--42.13M69.19%--------90.63M--90.56M0.08%104.66M15.57%110.41M5.49%110.37M0.03% Net finance costs ----3.33M--4.48M34.65%--------2.40M--7.19M199.13%9.58M33.25%10.55M10.17%10.81M2.44% Income tax ----0--2.83M--------------------------52.97M-- Operating profit ---------------------289.34M---203.63M29.62%-199.78M1.89%-117.39M41.24%14.97M112.75% Profit before tax -----47.71M---152.59M219.86%---------291.74M---210.82M27.74%-209.36M0.69%-127.95M38.89%4.16M103.25% Net profit -----47.71M---149.76M213.92%---------291.74M---210.82M27.74%-209.36M0.69%-127.95M38.89%57.13M144.65% Net profit attributable to owners -----31.06M---124.88M302.02%---------291.74M---210.82M27.74%-209.36M0.69%-127.95M38.89%57.13M144.65%

Revenue 274.18M--397.94M45.14% Other income and gains 6.01M--1.65M72.63% Cost of sales 32.94M--36.38M10.47% Gross profit 241.25M--361.56M49.87% Selling and distribution expenses 163.25M--254.40M55.84% Administrative expenses 51.37M--45.15M12.11% Net finance costs 5.42M--5.33M1.75% Income tax 0--0-- Profit before tax 2.90M--31.36M982.13% Net profit 2.90M--31.36M982.13% Net profit attributable to owners 2.90M--31.36M982.13%

Cash and cash equivalents ----76.44M--198.19M159.27%--------81.56M--33.57M58.84%173.34M416.40%89.34M48.46%109.26M22.29% Trade and bills receivables --------------------793.00K--9.53M1102.02%19.42M103.77%94.53M386.67%155.06M64.04% Inventories ----36.32M--27.55M24.14%--------53.21M--100.80M89.43%102.04M1.23%111.01M8.79%136.56M23.02% Total current assets ----154.94M--260.75M68.30%--------247.77M--201.12M18.83%342.21M70.15%365.77M6.89%434.30M18.73% Total assets --------------------899.90M--917.52M1.96%1.03B12.80%1.02B1.81%1.15B13.51% Total current liabilities ----70.85M--156.45M120.81%--------235.00M--188.40M19.83%316.19M67.83%312.12M1.29%534.04M71.10% Total liabilities --------------------297.92M--516.58M73.39%829.92M60.66%927.28M11.73%996.16M7.43% Equity attributable to owners ----99.81M--249.57M150.04%--------601.98M--400.94M33.40%205.06M48.86%88.93M56.63%157.30M76.88% Total equity ----153.29M--249.57M62.81%--------601.98M--400.94M33.40%205.06M48.86%88.93M56.63%157.30M76.88%

Cash and cash equivalents ----93.33M-- Trade and bills receivables ----150.47M-- Inventories ----145.01M-- Total current assets ----421.79M-- Total assets ----1.17B-- Total current liabilities ----503.59M-- Total liabilities ----974.78M-- Equity attributable to owners ----193.84M-- Total equity ----193.84M--

Net cash from operating activities -----65.12M---61.87M4.99%---------199.47M---56.88M71.48%57.39M200.89%-4.10M107.14%80.78M2071.25% Net cash from investing activities -----13.60M---82.71M508.27%---------179.42M---104.95M41.50%-3.50M96.66%-98.20M2701.63%-64.16M34.66% Net cash from financing activities ----16.90M--256.82M1419.91%---------17.78M--112.26M731.36%85.60M23.75%18.28M78.64%3.29M82.00% Net change in cash -----61.82M--112.24M281.55%---------396.67M---49.58M87.50%139.48M381.34%-84.02M160.23%19.91M123.70%

Net cash from operating activities 42.67M--64.70M51.62% Net cash from investing activities -24.41M---56.95M133.30% Net cash from financing activities -13.46M---23.67M75.87% Net change in cash 4.80M---15.92M431.57%